0
Your cart

Your cart is empty

Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology

Buy Now

Anticancer Agents from Natural Products (Hardcover, 2nd edition) Loot Price: R6,618
Discovery Miles 66 180
Anticancer Agents from Natural Products (Hardcover, 2nd edition): Gordon M. Cragg, David G. I. Kingston, David J. Newman

Anticancer Agents from Natural Products (Hardcover, 2nd edition)

Gordon M. Cragg, David G. I. Kingston, David J. Newman

 (sign in to rate)
Loot Price R6,618 Discovery Miles 66 180 | Repayment Terms: R620 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

The approach to drug discovery from natural sources has yielded many important new pharmaceuticals inaccessible by other routes. In many cases the isolated natural product may not be an effective drug for any of several reasons, but it nevertheless may become a drug through chemical modification or have a novel pharmacophore for future drug design. In summarizing the status of natural products as cancer chemotherapeutics, Anticancer Agents from Natural Products, Second Edition covers the: History of each covered drug-a discussion of its mechanism on action, medicinal chemistry, synthesis, and clinical applications Potential for novel drug discovery through the use of genome mining as well as future developments in anticancer drug discovery Important biosynthetic approaches to "unnatural" natural products Anticancer Agents from Natural Products, Second Edition discusses how complex target-oriented synthesis-enabled by historic advances in methodology-has enormously expanded the scope of the possible. This book covers the current clinically used anticancer agents that are either natural products or are clearly derived from natural product leads. It also reviews drug candidates currently in clinical development since many of these will be clinically used drugs in the future. Examples include the drugs etoposide and teniposide derived from the lead compound podophyllotoxin; numerous analogs derived from taxol; topotecan, derived from camptothecin; and the synthetic clinical candidates, E7389 and HTI-286, developed from the marine leads, halichondrin B and hemiasterlin.

General

Imprint: Crc Press
Country of origin: United States
Release date: October 2011
First published: 2011
Editors: Gordon M. Cragg • David G. I. Kingston • David J. Newman
Dimensions: 254 x 178 x 43mm (L x W x T)
Format: Hardcover
Pages: 784
Edition: 2nd edition
ISBN-13: 978-1-4398-1382-9
Categories: Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy
LSN: 1-4398-1382-5
Barcode: 9781439813829

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners